Studies by Gao et al. suggest that de-acetylation of PD-L1 at lysine 263 is essential for its nuclear translocation and for the modulation of gene expression affecting tumor aggressiveness and responsiveness to immune checkpoint therapy [4]. The gene discussed is CD274; the disease is neoplasm.